Skip to main content
Log in

Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The metabolism of cephaeline and emetine, which are the primary active components of ipecac syrup, were investigated in rats. Cephaeline-6′-O-glucuronide was found to be a biliary metabolite of cephaeline. Cephaeline (6′-O-demethylemetine) and 9-O-demethylemetine were observed to be enzyme-hydrolyzed biliary metabolites of emetine. Cephaeline was conjugated to glucuronide, while emetine was demethylated to cephaeline and 9-O-demethylemetine, and may be conjugated to glucuronides afterwards. Urine, feces and bile were collected from rats within 48 hours following the administration of ipecac syrup containing tritium (3H)-labeled cephaeline or emetine. Metabolites were separated and quantified by thin layer chromatography (TLC) or high-performance liquid chromatography (HPLC). Biliary and urinary excretion rates of3H-cephaeline were 57.5% and 16.5% of the dose, respectively. Cephaeline-6′-O-glucuronide was comprised 79.5% of biliary radioactivity and 84.3% of urinary radioactivity. Unchanged cephaeline was detected in 42.4% of the dose in feces. Biliary excretion rate of3H-emetine was 6.9% of the dose. Emetine, cephaeline and 9-O-demethylemetine comprised 5.8%, 43.2% and 13.6% in hydrolyzed bile, respectively. There were no emetine-derived metabolites in urine or feces. The occurrence of unchanged emetine was 6.8% and 19.7% of the dose in urine and feces, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Reference

  1. Manno B.R., Manno J. E. (1977): Toxicology of Ipecac: a review, Clin. Toxicol. 10:221–242.

    Article  PubMed  CAS  Google Scholar 

  2. Asano T., Ishihara K., Yanagisawa T., Kimura M., Kamei H., Yoshida T., Kuroiwa Y., Fujii Y., Yamashita M., Kuramochi T., Tomisawa H., Tateishi M. (2002): Absorption, distribution and excretion of 3H-labeled cephaeline and emetine spiked ipecac syrup in rats. Eur. J. Drug Metab. Pharmacokinet 27:17–28.

    PubMed  CAS  Google Scholar 

  3. Sobiczewska M., Borkowski B. (1970): Determination of cephaeline in Radix Ipecacuanhae. Acta. Pol. Pharm. 27:469–472.

    PubMed  CAS  Google Scholar 

  4. Fujii T., Ohba M. (1985): Quinolizidines. XI. Structure determination of the Alangium Alkaloid desmethylpsychotrine through synthetic incorporation of ethyl cincholoiponate into (+)-9-demethylpsychotrine. Chem. Pharm. Bull. 33:583–590.

    CAS  Google Scholar 

  5. Fujii T., Ohba M., Suzuki, H. (1985): Quinolizidines. XII. Synthetic incorporation of ethyl cincholoiponate into a tricyclic intermediate adaptable to chiral syntheses of the 10-hydroxy-9-methoxybenzo[a]quinolizidine-Type Alangium Alkaloids. Chem. Pharm. Bull. 33:1023–1028.

    CAS  Google Scholar 

  6. Fujii T., Ohba M. (1985): Quinolizidines. XVI. Chiral syntheses of 9-demethylcephaeline and 10-demethylcephaeline. Chem. Pharm. Bull. 33:5264–5269.

    CAS  Google Scholar 

  7. Budzikiewicz H., Pakrashi S.C., Vorbr ggen H. (1964): Die isolierung von emetin, cephaelin und psychotrin aus Alagium Lamarckkii und die identifizierung von Almarckine mit N-methylcephaelin. Tetrahedron 20:399–408.

    Article  CAS  Google Scholar 

  8. Peeples A, Dalvi R. R. (1982): Toxic alkaloids and their interaction with microsomal cytochrome P-450 in vitro. J. Appl. Toxicol. 2:300–302.

    Article  PubMed  CAS  Google Scholar 

  9. Halbing L., Gutmann L., Goebel H., Brick J. F., Schochet, S. (1988): Ultrastructural pathology in emetine-induced myopathy. Acta Neuropathol. 75:577–582.

    Article  Google Scholar 

  10. Adler A. G., Walinsky P., Krall R. A., Cho S. Y. (1980): Death resulting from ipecac syrup poisoning. JAMA 243:1927–1928.

    Article  PubMed  CAS  Google Scholar 

  11. Dresser L. P., Massey E., Johnson E. E., Bossen E. (1993): Ipecac myopathy and cardiomyopathy. J. Neurol. Neurosurg. Psychiatry. 56: 560–562.

    Article  PubMed  CAS  Google Scholar 

  12. Sugie H., Russin R., Verity M. A. (1984): Emetine myopathy: two case reports with pathobiochemical analysis. Muscle Nerve 7:54–59.

    Article  PubMed  CAS  Google Scholar 

  13. Pan S. J., Combs A. B. (1995): Effects of pharmacological interventions on emetine cardiotoxicity in isolated perfused rat hearts. Toxicology. 97:93–104.

    Article  PubMed  CAS  Google Scholar 

  14. Wenzel D. G., Cosma G. N. (1984): A model system for measuring comparative toxicities of cardiotoxic drugs with cultured rat heart myocytes, edothelial cells and fibroblasts. I. emetine, chloroquine and metronidazole. Toxicology. 33:103–115.

    Article  PubMed  CAS  Google Scholar 

  15. Epstein D. (1932): The action of emetine and cephaeline on the circulation, uterus and intestine. Q. J. Pharm. Pharmacol. 5:21–32.

    CAS  Google Scholar 

  16. Roming R. A. (1984): Effects of pharmacological interventions on emetine cardiotoxicity in isolated perfused rat hearts. Am. J. Psychiatry. 141:1639.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asano, T., Watanabe, J., Sadakane, C. et al. Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats. Eur. J. Drug Metab. Pharmacokinet. 27, 29–35 (2002). https://doi.org/10.1007/BF03190402

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190402

Keywords

Navigation